You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
As seen here: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Copied:
"Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives."
In progress for diagnostic tests, but not necessarily for device.
We may not include devices in CIDO due to limitations in man-power resources and lack of use cases. In addition, OBI has included a lot of PPE devices. Although the EUA info are not in OBI PPE devices, all the EUA devices will be a subclasses of an OBI PPE device.
As seen here:
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Copied:
"Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives."
Based on FDA EUA mechanism, FDA provides emergency use authorizations (EUA) for many
High Complexity Molecular-Based Laboratory Developed Tests, like SARS-CoV-2 detection assays.
See: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#LDTs
also:
In Vitro Diagnostic Products
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidinvitrodev
Personal Protective Equipment and Related Devices:
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidppe
Ventilators and Other Medical Devices:
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidothermeddev
Therapeutics:
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidtherapeutics
Detailed Information for all COVID-19 EUAs, including authorizations and fact sheets
The information is quite useful and can be modeled and represented in CIDO.
-- Out of discussion by Asiyah Lin and Oliver He
The text was updated successfully, but these errors were encountered: